Search research articles
Contact Us
Filters
Showing results (51-60 of 118) with videos related to
Page
of 12
Sort By:
European Journal of Neurology
|
May 16, 2000
Expression of TNFalpha and TGFbeta1 in Guillain-Barré syndrome: correlation of a low TNFalpha-/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment
L M Ossege, E Sindern, B Voss, et al.
Journal of Neuroimmunology
|
December 10, 1998
Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II
L M Ossege, E Sindern, T Patzold, et al.
Acta Neurologica Scandinavica
|
August 1, 1997
Biologically active TGF-beta 1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients
J D Rollnik, E Sindern, C Schweppe, et al.
Journal of Neuroimmunology
|
May 26, 1998
Corticosteroids induce expression of transforming-growth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosis
L M Ossege, E Sindern, B Voss, et al.
Immunopharmacology
|
August 7, 1999
Immunomodulatory effects of IFNbeta-1b on the mRNA-expression of TGFbeta-1 and TNFalpha in vitro
L M Ossege, E Sindern, B Voss, et al.
International Immunopharmacology
|
June 16, 2001
Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis
L M Ossege, E Sindern, T Patzold, et al.
Journal of Neurology
|
December 5, 1998
The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome
T Patzold, E Sindern, L Ossege-Pohle, et al.
Journal of Neurology
|
March 1, 1996
Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain-Barré syndrome
E Sindern, K Schweppe, L M Ossege, et al.
Journal of the Neurological Sciences
|
June 20, 2001
Inflammatory polyradiculoneuropathy with spinal cord involvement and lethal [correction of letal] outcome after hepatitis B vaccination
E Sindern, J M Schröder, M Krismann, et al.
Journal of the Neurological Sciences
|
December 1, 1996
Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in cerebrospinal fluid cells in meningitis
L M Ossege, E Sindern, B Voss, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 118) with videos related to
Sort By:
Page
of 12
European Journal of Neurology
|
May 16, 2000
Expression of TNFalpha and TGFbeta1 in Guillain-Barré syndrome: correlation of a low TNFalpha-/TGFbeta1-mRNA ratio with good recovery and signs for immunoregulation within the cerebrospinal fluid compartment
L M Ossege, E Sindern, B Voss, et al.
Journal of Neuroimmunology
|
December 10, 1998
Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II
L M Ossege, E Sindern, T Patzold, et al.
Acta Neurologica Scandinavica
|
August 1, 1997
Biologically active TGF-beta 1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patients
J D Rollnik, E Sindern, C Schweppe, et al.
Journal of Neuroimmunology
|
May 26, 1998
Corticosteroids induce expression of transforming-growth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosis
L M Ossege, E Sindern, B Voss, et al.
Immunopharmacology
|
August 7, 1999
Immunomodulatory effects of IFNbeta-1b on the mRNA-expression of TGFbeta-1 and TNFalpha in vitro
L M Ossege, E Sindern, B Voss, et al.
International Immunopharmacology
|
June 16, 2001
Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis
L M Ossege, E Sindern, T Patzold, et al.
Journal of Neurology
|
December 5, 1998
The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome
T Patzold, E Sindern, L Ossege-Pohle, et al.
Journal of Neurology
|
March 1, 1996
Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain-Barré syndrome
E Sindern, K Schweppe, L M Ossege, et al.
Journal of the Neurological Sciences
|
June 20, 2001
Inflammatory polyradiculoneuropathy with spinal cord involvement and lethal [correction of letal] outcome after hepatitis B vaccination
E Sindern, J M Schröder, M Krismann, et al.
Journal of the Neurological Sciences
|
December 1, 1996
Expression of tumor necrosis factor-alpha and transforming growth factor-beta 1 in cerebrospinal fluid cells in meningitis
L M Ossege, E Sindern, B Voss, et al.
Page
of 12